Keywords: qlt, sees, 3rd-qtr, profit, job, cuts, planned
QLT sees 3rd-qtr profit, but job cuts planned
Article | 05 November 2007
The three months ended September 30, 2007, saw Canadian drugmaker QLT's net income reach $346,000, or breakeven per share, compared with the $3.7 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
